Clinical Trials Browser

Interventional × Delirium × 1 year × Clear all

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Phase 2/3 Active not recruiting

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT06256354 2026-03-09

Effects of Intraoperative Targeted Temperature Management on Incidence of Postoperative Delirium and Long-term Survival

Phase NA Recruiting

Delirium, Hypothermia

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07398066 2026-02-09

DEX-NEURO

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

NCT03012984 2026-01-08

Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium

Phase NA Completed

Agnosia, Delirium, Postoperative Complications

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Phase 2/3 Active not recruiting

Delirium, Neoplasm Metastasis, Recurrence

NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Phase 4 Terminated

Emergence Delirium, Delirium, Lung Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium